Importance of the lipophilic group in carbamates having histamine H3- receptor antagonist activity

Pharmazie

Volumn 55, Issue 5, 2000, Pages 349-355

  Kiec Kononowicz K ^a   Wiecek M ^a   Sasse, A ^e   Ligneau, X ^b   Elz, S ^e   Ganellin, C R ^e   Schwartz, J C ^c   Stark, H ^e   Schunack, W ^d  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Laboratoire Bioprojet   (France)

^c CENTRE PAUL BROCA   (France)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (1H IMIDAZOL 4 YL)PROPYL N (4 PENTENYL)CARBAMATE; 3 (1H IMIDAZOL 4 YL)PROPYL N (ALLYL)CARBAMATE; CARBAMIC ACID DERIVATIVE; CLOBENPROPIT; HISTAMINE H3 RECEPTOR ANTAGONIST; THIOPERAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN CHEMISTRY; CARBAMATES; CEREBRAL CORTEX; CHEMISTRY, PHYSICAL; GUINEA PIGS; HISTAMINE ANTAGONISTS; ILEUM; INDICATORS AND REAGENTS; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RATS; RECEPTORS, HISTAMINE H3; SYNAPTOSOMES;

EID: 0342699473     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Arrang, J.-M.; Garbarg, M.; Schwartz, J.-C.: Nature 302, 832 (1983)
2. Arrang, J.-M.; Garbarg, M; Schwartz, J.-C.: Neuroscience 23, 149 (1987)
3. Schlicker, E.; Malinowska, B.; Kathmann, M; Göthert, M.: Fundam. Clin. Pharmacol. 8, 128 (1994)
4. Coruzzi, G.; Bertaccini, G.; Schwartz, J.-C.: Naunyn-Schmiedeberg's Arch. Pharmacol. 343, 225 (1991)
5. Ichinose, M.; Stretton, C. D.; Schwartz, J.-C.; Barnes, P. J.: Br. J. Pharmacol. 97, 13 (1989)
6. Imamura, M.; Seyedi, N.; Lander, H. M.; Levi, R.: Circ. Res. 77, 206 (1995)
7. Schlicker, E.; Fink, K.; Detzner, M.; Göthert, M.: J. Neural. Transm., Gen. Sect. 93, 1 (1993)
8. Schlicker, E.; Betz, R.; Göthert, M.: Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 588 (1988)
9. Clapham, J.; Klipatrick, G. J.: Br. J. Pharmacol. 107, 919 (1992)
10. Fink, K.; Schlicker, E.; Göthert, M.: Adv. Biosci. 82, 125 (1991)
11. Yokohama, H; Onodera, K.; Jinuma, K.; Watanabe, T.: Eur. J. Pharmacol. 234, 129 (1993)
12. Yokoyama, H; Onodera, K.; Maeyama, K.; Sakurai, E.; Jinuma, K.; Leurs, R.; Timmerman, H.; Watanabe, T.: Eur. J. Pharmacol. 260, 23 (1994)
13. Monti, J. M.: Life Sci. 53, 1331 (1993)
14. Tedford, C. E.; Yates, S. L.; Pawlowski, G. P.; Nalwalk, J. W.; Hough, L. B.; Khan, M. A.; Phillips, J. G.; Durant, G. J.; Frederickson, R. C. A.: J. Pharmacol. Exp. Ther. 275, 589 (1995)
15. Meguro, K. I.; Yanai, K.; Sakai, N.; Sakurai, E.; Maeyama, K.; Sasaki, H.; Watanabe, T.: Pharmacol. Biochem. Behav. 50, 321 (1995)
16. Panula, P.; Kuokkanen, K.; Relja, M; Eriksson, K. S.: Sallmen, T.; Rinne, J. O.; Kalimo, H.: Soc. Neurosci. Abstr. 21, 1977 (1995)
17. Morrisset, S.; Traiffort, E.; Schwartz, J.-C.: Eur. J. Pharmacol. 315, R1-R2 (1996)
18. Arrang, J.-M.; Garbarg, M.; Lancelot, J.-C.; Lecomte, J.-M.; Pollard, H.; Robba, M.; Schunack, W.; Schwartz, J.-C.: Nature 327, 117 (1987)
19. Van der Goot, H.; Schepers, M. J. P.; Sterk, G. J.; Timmerman, H.: Eur. J. Med.. Chem. 27, 511 (1992)
20. Stark, H.; Schlicker, E.; Schunack, W.: Drugs Future 21, 507 (1996)
21. Stark, H.; Ligneau, X.; Arrang, J.-M.; Schwartz, J.-C.; Schunack, W.: Bioorg. Med. Chem. Lett. 8, 2011 (1998)
22. Ganellin, C. R.; Leurquin, F.; Piripitsi, A.; Arrang, J.-M.: Garbarg, M.; Ligneau, X.; Schunack, W.; Schwartz, J.-C.: Arch. Pharm. Pharm. Med. Chem. 331, 395 (1998)
23. Purand, K.; Stark, H.; Ligneau, X.; Garbarg, M.; Schwartz, J.-C.; Schunack, W.: Eur. J. Pharm. Sci. 2, 140 (1994)
24. Stark, H.; Purand, K.; Ligneau, X.; Rouleau, A.; Arrang, J.-M.; Garbarg, M.; Schwartz, J.-C.; Schunack, W.: J. Med. Chem. 39, 1157 (1996)
25. Sasse, A.; Kieć-Kononowicz, K.; Stark, H.; Motyl, M.; Reidemeister, S.; Ganellin, C. R.; Ligneau, X.; Schwartz, J.-C.; Schunack, W.: J. Med. Chem. 42. 593 (1999)
26. PALLAS for Windows 1.2; 1995, CompuDrug Chemistry Ltd.
27. Garbarg, M.; Arrang, J.-M.; Rouleau, A.; Ligneau, X.; Trung Tuong, M. D.; Schwartz, J.-C.; Ganellin, C. R.: J. Pharmacol. Exp. Ther. 263, 304 (1992)
28. Schlicker, E.; Kathmann, M.; Reidemeister, S.; Stark, H.; Schunack, W.: Br. J. Pharmacol. 112, 1043 (1994)
29. Hirschfeld, J.; Buschauer, A.; Elz, S.; Schunack, W.; Ruat, M.; Traiffort, E.; Schwartz, J.-C.: J. Med. Chem. 35, 2231 (1992)
30. Sellier, C.; Buschauer, A.; Elz, S.; Schunack, W.: Liebigs Ann. Chem. 317 (1992)
31. Stark, H.; Purand, K.; Hüls, A.; Ligneau, X.; Garbarg, M.; Schwartz, J.-C.; Schunack, W.: J. Med. Chem. 39, 1220 (1996)
32. Mitsunobu, O.: Synthesis 1 (1981)
33. Vogel's Textbook of Practical Organic Chemistry. IV Ed. Longman Group Limited, 1978
34. Vollinga, R. C.; Zuiderveld, O. P.; Scheerens, H.; Bast, A.; Timmermann, H.: Methods Find. Exp. Clin. Pharmacol. 14, 747 (1992)
35. Ligneau, X.; Garbarg, M.; Vizuette, M. L.; Diaz, J.; Purand, K.; Stark, H.; Schunack, W.; Schwartz, J.-C.: J. Pharmacol. Exp. Ther. 271, 452 (1994)
36. Krogsgaard-Larsen, P.; Liljefors, T.; Madsen, U. (ed.): A Textbook of drug design and development" Ed. 1I Ed. Harwood Academic Publishers, 1996
37. Whittaker, V. P.: Ann. N.Y. Acad. Sci. 137, 982 (1966)
38. Cheng, Y. C.; Prusoff, W. H.: Biochem. Pharmacol. 22, 3099 (1973)
39. Garbarg, M.; Pollard, H.; Trung Tuong, M. D.; Schwartz, J.-C.; Gros, C.: J. Neurochem. 53, 1724 (1989)
40. Ligneau, X.; Lin, J.-S.; Vanni-Mercier, G.; Jouvet, M.; Muir, J. L.; Ganellin, C. R.; Stark, H.; Elz, S.; Schunack, W.; Schwartz, J.-C.: J. Pharmacol. Exp. Ther. 287, 658 (1998)
41. Parker, R. B.; Waud, D. R.: J. Pharmacol. Exp. Ther. 177, 1 (1971)